Suppr超能文献

大鼠尾动脉对去甲肾上腺素、去氧肾上腺素、5-羟色胺和血管加压素产生反应期间,对α2肾上腺素能受体激动剂UK14304的血管收缩反应。

Vasoconstrictor responses to the alpha 2-adrenoceptor agonist UK14304 during responses to noradrenaline, phenylephrine, serotonin and vasopressin of the rat tail artery.

作者信息

Xiao X H, Rand M J

机构信息

Department of Pharmacology, University of Melbourne, Victoria, Australia.

出版信息

Arch Int Pharmacodyn Ther. 1990 Nov-Dec;308:63-75.

PMID:1983065
Abstract

In the isolated perfused rat tail artery, the alpha 2-adrenoceptor agonist UK14304 alone did not exert a direct vasoconstrictor action until a concentration of at least 30 microM was reached. However, when administered during the sustained vasoconstrictor response to 1.6 microM vasopressin, UK14304 (1-100 nM) produced additional concentration-dependent increases in perfusion pressure. The vasoconstrictor response to UK14304 in the presence of vasopressin was antagonized by idazoxan (1 microM) but was not affected by prazosin (10 nM), indicating that it was due to activation of alpha 2-adrenoceptors, and it was reduced by diltiazem (10 microM) and abolished when perfusion was done with a Ca2(+)-free solution, suggesting that the effect depends on the influx of Ca2+. UK14304 (50 nM) also produced a further increase in perfusion pressure when given during sustained vasoconstrictor responses to phenylephrine (1 microM) or low concentrations (100 nM) of noradrenaline or serotonin. However, UK14304 did not produce a further increase in perfusion pressure when given during sustained vasoconstrictor responses to higher concentrations (300 nM) of noradrenaline or serotonin: the lack of an additional effect of UK14304 was not due to the primary response to noradrenaline or serotonin being maximal. The findings show that vasoconstrictor responses following activation of alpha 2-adrenoceptors may be uncovered by an increase in vascular tone produced by some agonists.

摘要

在离体灌注的大鼠尾动脉中,α₂ - 肾上腺素能受体激动剂UK14304单独使用时,直到浓度至少达到30微摩尔/升才会产生直接的血管收缩作用。然而,当在对1.6微摩尔/升血管加压素的持续血管收缩反应期间给药时,UK14304(1 - 100纳摩尔/升)会使灌注压力产生额外的浓度依赖性升高。在血管加压素存在的情况下,UK14304引起的血管收缩反应可被咪唑克生(1微摩尔/升)拮抗,但不受哌唑嗪(10纳摩尔/升)影响,这表明该反应是由于α₂ - 肾上腺素能受体的激活所致,并且它会被地尔硫䓬(10微摩尔/升)减弱,当用无钙溶液进行灌注时则被消除,这表明该效应依赖于钙离子内流。当在对去氧肾上腺素(1微摩尔/升)、低浓度(100纳摩尔/升)的去甲肾上腺素或5 - 羟色胺的持续血管收缩反应期间给予UK14304(50纳摩尔/升)时,也会使灌注压力进一步升高。然而,当在对较高浓度(300纳摩尔/升)的去甲肾上腺素或5 - 羟色胺的持续血管收缩反应期间给予UK14304时,它不会使灌注压力进一步升高:UK14304缺乏额外效应并非由于对去甲肾上腺素或5 - 羟色胺的初始反应已达最大值。这些发现表明,一些激动剂引起的血管张力增加可能会揭示α₂ - 肾上腺素能受体激活后的血管收缩反应。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验